178 related articles for article (PubMed ID: 7619673)
21. Liver dysfunction markedly decreases the inhibition of cytochrome P450 1A2-mediated theophylline metabolism by fluvoxamine.
Orlando R; Padrini R; Perazzi M; De Martin S; Piccoli P; Palatini P
Clin Pharmacol Ther; 2006 May; 79(5):489-99. PubMed ID: 16678550
[TBL] [Abstract][Full Text] [Related]
22. Role of human microsomal and human complementary DNA-expressed cytochromes P4501A2 and P4503A4 in the bioactivation of aflatoxin B1.
Gallagher EP; Wienkers LC; Stapleton PL; Kunze KL; Eaton DL
Cancer Res; 1994 Jan; 54(1):101-8. PubMed ID: 8261428
[TBL] [Abstract][Full Text] [Related]
23. Effect of quinolone antimicrobials on theophylline pharmacokinetics.
Prince RA; Casabar E; Adair CG; Wexler DB; Lettieri J; Kasik JE
J Clin Pharmacol; 1989 Jul; 29(7):650-4. PubMed ID: 2760258
[TBL] [Abstract][Full Text] [Related]
24. Effects of CYP inducers and inhibitors on the pharmacokinetics of intravenous theophylline in rats: involvement of CYP1A1/2 in the formation of 1,3-DMU.
Yang KH; Lee JH; Lee MG
J Pharm Pharmacol; 2008 Jan; 60(1):45-53. PubMed ID: 18088504
[TBL] [Abstract][Full Text] [Related]
25. Inhibitory potency of quinolone antibacterial agents against cytochrome P450IA2 activity in vivo and in vitro.
Fuhr U; Anders EM; Mahr G; Sörgel F; Staib AH
Antimicrob Agents Chemother; 1992 May; 36(5):942-8. PubMed ID: 1510417
[TBL] [Abstract][Full Text] [Related]
26. Identification and characterization of the cytochrome P450 enzymes involved in N-dealkylation of propafenone: molecular base for interaction potential and variable disposition of active metabolites.
Botsch S; Gautier JC; Beaune P; Eichelbaum M; Kroemer HK
Mol Pharmacol; 1993 Jan; 43(1):120-6. PubMed ID: 8423765
[TBL] [Abstract][Full Text] [Related]
27. Effects of phenothiazine neuroleptics on the rate of caffeine demethylation and hydroxylation in the rat liver.
Daniel WA; Syrek M; Ryłko Z; Kot M
Pol J Pharmacol; 2001; 53(6):615-21. PubMed ID: 11985335
[TBL] [Abstract][Full Text] [Related]
28. Co-administration of ciprofloxacin and cyclosporin: lack of evidence for a pharmacokinetic interaction.
Tan KK; Trull AK; Shawket S
Br J Clin Pharmacol; 1989 Aug; 28(2):185-7. PubMed ID: 2775624
[TBL] [Abstract][Full Text] [Related]
29. The effect of chronic cadmium exposure on the pharmacokinetics of theophylline and ciprofloxacin in rats.
Zaghloul IY; Radwan MA; Aly ZH
J Trace Elem Med Biol; 2007; 21(2):132-7. PubMed ID: 17499154
[TBL] [Abstract][Full Text] [Related]
30. Metabolism and elimination of quinine in healthy volunteers.
Mirghani RA; Hellgren U; Bertilsson L; Gustafsson LL; Ericsson O
Eur J Clin Pharmacol; 2003 Sep; 59(5-6):423-7. PubMed ID: 12920491
[TBL] [Abstract][Full Text] [Related]
31. Inhibition of caffeine metabolism by ciprofloxacin in children with cystic fibrosis as measured by the caffeine breath test.
Parker AC; Preston T; Heaf D; Kitteringham NR; Choonara I
Br J Clin Pharmacol; 1994 Dec; 38(6):573-6. PubMed ID: 7888295
[TBL] [Abstract][Full Text] [Related]
32. Prediction of inter-individual variability on the pharmacokinetics of CYP1A2 substrates in non-smoking healthy volunteers.
Haraya K; Kato M; Chiba K; Sugiyama Y
Drug Metab Pharmacokinet; 2016 Aug; 31(4):276-84. PubMed ID: 27318879
[TBL] [Abstract][Full Text] [Related]
33. CYP1A2 activity as a risk factor for bladder cancer.
Lee SW; Jang IJ; Shin SG; Lee KH; Yim DS; Kim SW; Oh SJ; Lee SH
J Korean Med Sci; 1994 Dec; 9(6):482-9. PubMed ID: 7786445
[TBL] [Abstract][Full Text] [Related]
34. Effects of antidepressant drugs on the activity of cytochrome P-450 measured by caffeine oxidation in rat liver microsomes.
Danie WA; Syrek M; Ryłko Z; Wójcikowski J
Pol J Pharmacol; 2001; 53(4):351-7. PubMed ID: 11990081
[TBL] [Abstract][Full Text] [Related]
35. Interaction between the fluoroquinolones and the bronchodilator theophylline.
Wijnands WJ; Vree TB
J Antimicrob Chemother; 1988 Sep; 22 Suppl C():109-14. PubMed ID: 3053575
[TBL] [Abstract][Full Text] [Related]
36. Pharmacokinetic changes of unbound theophylline are due to plasma protein binding displacement and CYP1A2 activity inhibition by baicalin in rats.
Gao N; Fang Y; Qi B; Jia LJ; Jin H; Qiao HL
J Ethnopharmacol; 2013 Nov; 150(2):477-84. PubMed ID: 24076258
[TBL] [Abstract][Full Text] [Related]
37. Metabolism of fentanyl, a synthetic opioid analgesic, by human liver microsomes. Role of CYP3A4.
Feierman DE; Lasker JM
Drug Metab Dispos; 1996 Sep; 24(9):932-9. PubMed ID: 8886601
[TBL] [Abstract][Full Text] [Related]
38. The involvement of CYP1A2 and CYP3A4 in the metabolism of clozapine.
Eiermann B; Engel G; Johansson I; Zanger UM; Bertilsson L
Br J Clin Pharmacol; 1997 Nov; 44(5):439-46. PubMed ID: 9384460
[TBL] [Abstract][Full Text] [Related]
39. Inhibition of cytochrome P-450 3A (CYP3A) in human intestinal and liver microsomes: comparison of Ki values and impact of CYP3A5 expression.
Gibbs MA; Thummel KE; Shen DD; Kunze KL
Drug Metab Dispos; 1999 Feb; 27(2):180-7. PubMed ID: 9929500
[TBL] [Abstract][Full Text] [Related]
40. Failure of ceftibuten to alter single dose theophylline clearance.
Bachmann K; Schwartz J; Jauregui L; Martin M; Nunlee M
J Clin Pharmacol; 1990 May; 30(5):444-8. PubMed ID: 2347955
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
